Alphabet Inc’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-23,205
Closed -$2.36M 28
2025
Q4
$2.36M Hold
23,205
0.09% 22
2025
Q3
$1.27M Hold
23,205
0.05% 31
2025
Q2
$1.23M Hold
23,205
0.06% 29
2025
Q1
$1M Hold
23,205
0.06% 30
2024
Q4
$1.3M Hold
23,205
0.08% 29
2024
Q3
$1.58M Hold
23,205
0.09% 29
2024
Q2
$980K Hold
23,205
0.05% 35
2024
Q1
$1.6M Hold
23,205
0.06% 33
2023
Q4
$1.72M Hold
23,205
0.08% 32
2023
Q3
$1.58M Hold
23,205
0.1% 34
2023
Q2
$2.18M Hold
23,205
0.12% 32
2023
Q1
$1.57M Hold
23,205
0.09% 35
2022
Q4
$1.15M Hold
23,205
0.07% 44
2022
Q3
$754K Hold
23,205
0.04% 43
2022
Q2
$914K Hold
23,205
0.05% 47
2022
Q1
$1.62M Hold
23,205
0.05% 49
2021
Q4
$1.81M Hold
23,205
0.04% 51
2021
Q3
$2.21M Buy
+23,205
New +$2.45M 0.05% 40

Other funds holding EXAS

Alphabet Inc's EXAS Position: Q1 2026 in Review

Alphabet Inc sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 23,205 shares — an estimated $2.36M sold.

Alphabet Inc first reported a position in EXAS in Q3 2021 and held it in 18 quarters. The position peaked at $2.36M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Alphabet Inc reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Alphabet Inc sold 23,205 Exact Sciences shares in Q1 2026, an estimated $2.36M.
  • Alphabet Inc first reported a position in Exact Sciences in Q3 2021 and held it in 18 quarters.
  • Alphabet Inc's Exact Sciences position peaked at $2.36M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Alphabet Inc's 13F filing for Q1 2026, filed 8 May 2026.